Pfizer opens £26.3m UK biotech packaging expansion
Pfizer has invested £26.3m ($41.7m) into a new facility at its biotech packaging and distribution site in Havant, UK.
Pfizer has invested £26.3m ($41.7m) into a new facility at its biotech packaging and distribution site in Havant, UK.
IDT Biologika.says demand for vaccines in emerging markets is big chance for Big Pharma and hence a growing niche for contractors with the technical capabilities to carry out such work.
Covance has forged a new deal with InPhoton to provide clients with access to intravital microscopy imaging technology to address drug discovery and development questions across the preclinical space.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including board elections at ISPE and appointments at Advaxis and Asubio.
A strategic partnership between New England IRB (NEIRB) and Veritas IRB of Montreal will see their clients following a common protocol review for studies they conduct throughout the US and Canada.
Data from a study comparing an oral spray formulation of sildenafil citrate to Viagra has been presented by NovaDel Pharma.
Drug delivery and pharmaceutical coating technologies firm SurModics will cut jobs and reorganise operations in a bid to reverse falling revenues and tumbling profits.
Beta-Pro is addressing rising demands from drug discovery and research institutes in the hepatocyte market by expanding its site at the University of Virginia Research Park, US, with a new GLP facility.